ORs of each serum amylase for NAFLD of moderate or severe grade
| Serum amylase quartiles | Q1 (highest) | Q2 | Q3 | Q4 (lowest) | p for trend |
|---|---|---|---|---|---|
| N* | 320 | 316 | 308 | 289 | |
| Model 1 | 1 | 1.29 (0.80 to 2.09) | 2.04 (1.29 to 3.20) | 3.51 (2.27 to 5.42) | <0.0001 |
| Model 2 | 1 | 1.36 (0.83 to 2.22) | 2.14 (1.33 to 3.44) | 3.81 (2.40 to 6.05) | <0.0001 |
| Model 3 | 1 | 1.61 (0.91 to 2.86) | 2.32 (1.32 to 4.07) | 3.45 (1.99 to 6.00) | <0.0001 |
| Model 4 | 1 | 1.48 (0.84 to 2.64) | 2.11 (1.19 to 3.73) | 2.97 (1.70 to 5.20) | <0.0001 |
| Model 5 | 1 | 1.56 (0.89 to 2.75) | 2.32 (1.33 to 4.04) | 3.26 (1.88 to 5.66) | <0.0001 |
| Model 6 | 1 | 1.05 (0.54 to 2.03) | 1.44 (0.76 to 2.72) | 2.01 (1.07 to 3.78) | 0.01 |
| Model 7 | 1 | 1.06 (0.55 to 2.05) | 1.37 (0.73 to 2.59) | 2.06 (1.09 to 3.87) | 0.01 |
*Subjects with mild NAFLD (n=242) were excluded from this analysis. Models 1–7 are the same as those in table 2.
NAFLD, non-alcoholic fatty liver disease.